MannKind Corp. (MNKD)

4.06 +0.10 (+2.53%) USD  |  NASDAQ  |  Sep 04, 16:00
4.03 -0.03 (-0.74%) After-Hours: 20:00
More

MannKind SG&A Expense (TTM) : 341.36M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for MNKD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2002. Start Trial.
Date Value
June 30, 2026 341.36M
March 31, 2026 288.00M
December 31, 2025 229.86M
September 30, 2025 195.42M
June 30, 2025 161.16M
March 31, 2025 122.03M
December 31, 2024 94.33M
September 30, 2024 90.89M
June 30, 2024 90.95M
March 31, 2024 92.79M
December 31, 2023 94.31M
September 30, 2023 95.87M
June 30, 2023 94.53M
March 31, 2023 94.63M
December 31, 2022 91.47M
September 30, 2022 92.10M
June 30, 2022 86.69M
March 31, 2022 80.70M
December 31, 2021 77.42M
September 30, 2021 71.81M
June 30, 2021 68.49M
March 31, 2021 62.10M
December 31, 2020 59.04M
September 30, 2020 57.64M
June 30, 2020 60.41M
Date Value
March 31, 2020 63.35M
December 31, 2019 74.67M
September 30, 2019 76.92M
June 30, 2019 79.65M
March 31, 2019 84.77M
December 31, 2018 79.72M
September 30, 2018 85.02M
June 30, 2018 83.35M
March 31, 2018 80.19M
December 31, 2017 74.96M
September 30, 2017 67.01M
June 30, 2017 62.42M
March 31, 2017 54.97M
December 31, 2016 46.93M
September 30, 2016 39.91M
June 30, 2016 38.32M
March 31, 2016 37.83M
December 31, 2015 40.96M
September 30, 2015 45.19M
June 30, 2015 52.73M
March 31, 2015 74.63M
December 31, 2014 79.38M
September 30, 2014 84.47M
June 30, 2014 82.86M
March 31, 2014 64.87M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
United Therapeutics Corp. 644.60M
ACADIA Pharmaceuticals, Inc. 620.29M
Gilead Sciences, Inc. 9.147B
Vertex Pharmaceuticals, Inc. 2.008B
Ocugen, Inc. 29.72M